Published in Hepatitis Weekly, January 29th, 2001
Tests comparing the two drugs were conducted by Schering Plough Corporation researchers and reported in Clinical Pharmacology and Therapeutics.
"Fifty-eight patients (38 men, 20 women; age range, 25 to 65 years) with compensated chronic hepatitis C were enrolled in this open-label, randomized, active controlled study," said P. Glue and colleagues at the pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.